Point72 Asset Management’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-729,628
Closed -$18.5M 1662
2019
Q1
$18.5M Sell
729,628
-604,012
-45% -$10.7M 0.08% 273
2018
Q4
$15.4M Sell
1,333,640
-193,589
-13% -$2.58M 0.08% 318
2018
Q3
$31.2M Buy
+1,527,229
New +$31.3M 0.13% 212

Point72 Asset Management's NITE Position: Q2 2019 in Review

Point72 Asset Management sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 729,628 shares — an estimated $18.5M sold.

Point72 Asset Management first reported a position in NITE in Q3 2018 and held it in 3 quarters. The position peaked at $31.2M in Q3 2018. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

  • Point72 Asset Management reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • Point72 Asset Management sold 729,628 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $18.5M.
  • Point72 Asset Management first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2018 and held it in 3 quarters.
  • Point72 Asset Management's Nightstar Therapeutics plc American Depositary Shares position peaked at $31.2M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Point72 Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.